This article only represents the author's own views.
The “Rule of 10” is a widely accepted yardstick within the biopharma industry for the chances of commercial success.
According to the adage, it takes around 10 years and $1 billion to develop a viable innovative drug, but only around 10% of prospective products make the grade, with the rest falling by the wayside.
您已阅读7%（366字），剩余93%（5186字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。